UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 5.038

Sortiert nach

Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation

Oncogene, 2010-09, Vol.29 (37), p.5135-5145

2010

Volltextzugriff (PDF)

EGF mutant receptor vIII as a molecular target in cancer therapy

Endocrine-related cancer, 2001-06, Vol.8 (2), p.83-96

2001

Volltextzugriff (PDF)

Regional Treatment of Epidermal Growth Factor Receptor vIII-expressing Neoplastic Meningitis with a Single-Chain Immunotoxin, MR-1

Clinical cancer research, 1999-09, Vol.5 (9), p.2646-2652

1999

Volltextzugriff (PDF)

Recombinant heregulin-Pseudomonas exotoxin fusion proteins: interactions with the heregulin receptors and antitumor activity in vivo

Clinical cancer research, 1998-04, Vol.4 (4), p.993-1004

1998

Volltextzugriff (PDF)

Pseudomonas exotoxin A mutants. Replacement of surface exposed residues in domain II with cysteine residues that can be modified with polyethylene glycol in a site-specific manner

The Journal of biological chemistry, 1994-03, Vol.269 (10), p.7610-7616

1994

Volltextzugriff (PDF)

Improved antitumor activity of a recombinant anti-Lewis(y) immunotoxin not requiring proteolytic activation

Proceedings of the National Academy of Sciences - PNAS, 1996-02, Vol.93 (3), p.974-978

1996

Volltextzugriff (PDF)

Further evidence that transposition of Tn5 in Escherichia coli is strongly enhanced by constitutively activated RecA proteins

Journal of Bacteriology, 1992-11, Vol.174 (21), p.6872-6877

1992

Volltextzugriff (PDF)

Recognition of glioma stem cells by genetically modified T cells targeting EGFRvIII and development of adoptive cell therapy for glioma

Human gene therapy, 2012-10, Vol.23 (10), p.1043

2012

Volltextzugriff (PDF)

Expression of recombinant anticoagulant hirudin in the differentiated cultures of the porcine mammary epithelial cell line SI-PMEC

Cell biology international, 2008-07, Vol.32 (7), p.739-747

2008

Volltextzugriff (PDF)

Phase I Trial Results of Iodine-131–Labeled Antitenascin Monoclonal Antibody 81C6 Treatment of Patients With Newly Diagnosed Malignant Gliomas

Journal of clinical oncology, 2000-11, Vol.18 (22), p.3862-3872

2000

Volltextzugriff (PDF)

LexA protein of Escherichia coli represses expression of the Tn5 transposase gene

Journal of Bacteriology, 1991-10, Vol.173 (20), p.6406-6410

1991

Volltextzugriff (PDF)

Excision and Transposition of Tn5 as an SOS Activity in Escherichia coli

Genetics (Austin), 1991-05, Vol.128 (1), p.45-57

1991

Volltextzugriff (PDF)

Increased binding affinity enhances targeting of glioma xenografts by EGFRvIII‐specific scFv

International journal of cancer, 2000-12, Vol.88 (6), p.962-969

2000

Volltextzugriff (PDF)

Immunotoxins containing Pseudomonas exotoxin that target LeY damage human endothelial cells in an antibody-specific mode: relevance to vascular leak syndrome

Clinical cancer research, 1995-12, Vol.1 (12), p.1589-1594

1995

Volltextzugriff (PDF)

Three dimensional optic disc visualisation from stereo images via dual registration and ocular media optical correction

British journal of ophthalmology, 2006-02, Vol.90 (2), p.181-185

2006

Volltextzugriff (PDF)

EGFRvIII as a promising target for antibody-based brain tumor therapy

Brain tumor pathology, 2000-06, Vol.17 (2), p.71-78

2000

Volltextzugriff (PDF)

The changes of matrix metalloproteinase-2 and -9 enzyme activities in the children with ventricular septal defect

European heart journal, 2013-08, Vol.34 (suppl 1), p.P3894-P3894

2013

Volltextzugriff (PDF)

Design of a Novel Small Peptide Targeted against a Tumor-Specific Receptor

Biochemical and biophysical research communications, 2000-08, Vol.275 (2), p.631-636

2000

Volltextzugriff (PDF)

NEXT-GENERATION RECOMBINANT IMMUNOTOXINS FOR GLIOBLASTOMAS AND MELANOMAS TREATMENT

Neuro-oncology (Charlottesville, Va.), 2014-07, Vol.16 (suppl 3), p.iii43-iii43

2014

Volltextzugriff (PDF)

Recombinant Immunotoxin Containing a Disulfide-Stabilized Fv Directed at erbB2 That Does Not Require Proteolytic Activation

Biochemistry (Easton), 1996-03, Vol.35 (9), p.2872-2877

1996

Volltextzugriff (PDF)

125I-labeled Anti-Epidermal Growth Factor Receptor-vIII Single-Chain Fv Exhibits Specific and High-Level Targeting of Glioma Xenografts

Clinical cancer research, 1999-06, Vol.5 (6), p.1539-1549

1999

Volltextzugriff (PDF)

IDH1 MUTATIONS AS A IMMUNOTHERAPEUTIC TARGET FOR BRAIN TUMORS

Neuro-oncology (Charlottesville, Va.), 2014-07, Vol.16 (suppl 3), p.iii40-iii40

2014

Volltextzugriff (PDF)

Affinity-matured recombinant immunotoxin targeting gangliosides 3′-isoLM1 and 3′,6'-isoLD1 on malignant gliomas

mAbs, 2013-09, Vol.5 (5), p.748-762

2013

Volltextzugriff (PDF)

Glycoprotein Nonmetastatic Melanoma Protein B, a Potential Molecular Therapeutic Target in Patients with Glioblastoma Multiforme

Clinical cancer research, 2006-04, Vol.12 (7), p.1970-1982

2006

Volltextzugriff (PDF)

Bone-related Genes Expressed in Advanced Malignancies Induce Invasion and Metastasis in a Genetically Defined Human Cancer Model

The Journal of biological chemistry, 2003-05, Vol.278 (18), p.15951-15957

2003

Volltextzugriff (PDF)

1 – 25 von 5.038

Suche als RSS-Feed

Aktive Filter

ThemaChemistry

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.969)
Mit Volltextzugriff
(4.539)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(3.753)
Life Sciences & Biomedicine
(2.102)
Humans
(1.543)
Technology
(1.351)
Female
(886)
Male
(839)
Engineering
(788)
Middle Aged
(637)
Biological And Medical Sciences
(632)
Physical Sciences
(615)
Engineering, Electrical & Electronic
(585)
Computer Science
(573)
Adult
(552)
Medical Sciences
(487)
Aged
(468)
Animals
(465)
Exact Sciences And Technology
(438)
Physics
(413)
Applied Sciences
(320)
Physics, Applied
(282)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation

EGF mutant receptor vIII as a molecular target in cancer therapy

Regional Treatment of Epidermal Growth Factor Receptor vIII-expressing Neoplastic Meningitis with a Single-Chain Immunotoxin, MR-1

Recombinant heregulin-Pseudomonas exotoxin fusion proteins: interactions with the heregulin receptors and antitumor activity in vivo

Pseudomonas exotoxin A mutants. Replacement of surface exposed residues in domain II with cysteine residues that can be modified with polyethylene glycol in a site-specific manner

Improved antitumor activity of a recombinant anti-Lewis(y) immunotoxin not requiring proteolytic activation

Further evidence that transposition of Tn5 in Escherichia coli is strongly enhanced by constitutively activated RecA proteins

Recognition of glioma stem cells by genetically modified T cells targeting EGFRvIII and development of adoptive cell therapy for glioma

Expression of recombinant anticoagulant hirudin in the differentiated cultures of the porcine mammary epithelial cell line SI-PMEC

Phase I Trial Results of Iodine-131–Labeled Antitenascin Monoclonal Antibody 81C6 Treatment of Patients With Newly Diagnosed Malignant Gliomas

LexA protein of Escherichia coli represses expression of the Tn5 transposase gene

Excision and Transposition of Tn5 as an SOS Activity in Escherichia coli

Increased binding affinity enhances targeting of glioma xenografts by EGFRvIII‐specific scFv

Immunotoxins containing Pseudomonas exotoxin that target LeY damage human endothelial cells in an antibody-specific mode: relevance to vascular leak syndrome

Three dimensional optic disc visualisation from stereo images via dual registration and ocular media optical correction

EGFRvIII as a promising target for antibody-based brain tumor therapy

The changes of matrix metalloproteinase-2 and -9 enzyme activities in the children with ventricular septal defect

Design of a Novel Small Peptide Targeted against a Tumor-Specific Receptor

NEXT-GENERATION RECOMBINANT IMMUNOTOXINS FOR GLIOBLASTOMAS AND MELANOMAS TREATMENT

Recombinant Immunotoxin Containing a Disulfide-Stabilized Fv Directed at erbB2 That Does Not Require Proteolytic Activation

125I-labeled Anti-Epidermal Growth Factor Receptor-vIII Single-Chain Fv Exhibits Specific and High-Level Targeting of Glioma Xenografts

IDH1 MUTATIONS AS A IMMUNOTHERAPEUTIC TARGET FOR BRAIN TUMORS

Affinity-matured recombinant immunotoxin targeting gangliosides 3′-isoLM1 and 3′,6'-isoLD1 on malignant gliomas

Glycoprotein Nonmetastatic Melanoma Protein B, a Potential Molecular Therapeutic Target in Patients with Glioblastoma Multiforme

Bone-related Genes Expressed in Advanced Malignancies Induce Invasion and Metastasis in a Genetically Defined Human Cancer Model

Aktive Filter

Suchergebnisse filtern